Open innovation: A Paradigm Shift in Pharma R&D?
The Science Direct website reported that Open innovation (OI) holds promise to accelerate, diversify, and innovate research and development (R&D) in the pharmaceutical industry. It remains to be assessed in which way and to what extent OI is leveraged in practice by current pharmaceutical R&D organizations. Therefore, here we comprehensively
Comments Off on Open innovation: A Paradigm Shift in Pharma R&D? • Read this story »
More Articles
Korean Drugmakers Seek Global Collaboration for Open Innovation
The Korea Biomedical Review reported that open innovation has become a major strategy for Korean pharmaceutical companies to develop new drugs. They are increasingly going beyond the border to collaborate with foreign companies or research institutes for global open innovation. Pharmaceutical industry
Comments Off on Korean Drugmakers Seek Global Collaboration for Open Innovation • Read this story »
A Joint Front: Open Source Pharma
An article on the Business Today (India) website noted that an open source drug discovery program allows capabilities to be linked and used, at negligible cost. India has already taken a step in this direction. Bill Gates, who built his empire on proprietary software, tweeted that open innovation
Comments Off on A Joint Front: Open Source Pharma • Read this story »